University College London, UK.
Hist Psychiatry. 2022 Mar;33(1):65-78. doi: 10.1177/0957154X211062538. Epub 2021 Dec 22.
This paper examines the evidence behind the use and decline of insulin coma therapy as a treatment for schizophrenia and how this was viewed by the psychiatric profession. The paper demonstrates that, from the time of its introduction, there was considerable debate regarding the evidence for insulin treatment, and scepticism about its purported benefits. The randomized trials conducted in the 1950s were the result, rather than the origins, of this debate. Although insulin treatment was subsequently abandoned, it was still regarded as a historic moment in the modernization of psychiatry. Then, as now, evidence does not speak for itself, and insulin continued to be incorporated into the story of psychiatric progress even after it was shown to be ineffective.
本文考察了胰岛素昏迷疗法作为精神分裂症治疗方法的应用和衰落背后的证据,以及精神病学界对此的看法。本文表明,从引入胰岛素治疗开始,就有相当多的争议围绕着它的疗效证据,人们对其所谓的益处持怀疑态度。20 世纪 50 年代进行的随机试验是这一争论的结果,而不是起源。尽管胰岛素治疗随后被放弃,但它仍被视为精神病学现代化的一个历史时刻。当时和现在一样,证据本身并不会说话,即使胰岛素治疗被证明无效,它仍然被纳入精神病学进步的故事中。